Unravelling the functional genomics of the human CYP2D6 gene locus

被引：30
作者：
Ingelman-Sundberg, M [1 ]
Evans, WE
机构：
[1] Karolinska Inst, IMM, Div Mol Toxicol, Stockholm, Sweden
[2] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
来源：
PHARMACOGENETICS | 2001年 / 11卷 / 07期
关键词：
D O I：
10.1097/00008571-200110000-00002
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：553 / 554
页数：2
相关论文
共 5 条
[1]   Pharmacogenomics: Translating functional genomics into rational therapeutics [J].
Evans, WE ;
Relling, MV .
SCIENCE, 1999, 286 (5439) :487-491
[2]   Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment [J].
Ingelman-Sundberg, M ;
Oscarson, M ;
McLellan, RA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (08) :342-349
[3]   EVIDENCE FOR ALTERED CATALYTIC PROPERTIES OF THE CYTOCHROME-P-450 INVOLVED IN SPARTEINE OXIDATION IN POOR METABOLIZERS [J].
OSIKOWSKAEVERS, B ;
DAYER, P ;
MEYER, UA ;
ROBERTZ, GM ;
EICHELBAUM, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (03) :320-325
[4]   Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6 [J].
Raimundo, S ;
Fischer, R ;
Eichelbaum, M ;
Griese, EU ;
Schwab, M ;
Zanger, UM .
PHARMACOGENETICS, 2000, 10 (07) :577-581
[5]   Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6 [J].
Zanger, UM ;
Fischer, J ;
Raimundo, S ;
Stüven, T ;
Evert, BO ;
Schwab, M ;
Eichelbaum, M .
PHARMACOGENETICS, 2001, 11 (07) :573-585
1